Expression of promyelocytic leukaemia protein in thyroid neoplasms

Histopathology

Volumn 37, Issue 4, 2000, Pages 302-308

  Yu, E ^a   Lee, K W ^a,b   Lee, H J ^a  

^a University of Ulsan College of Medicine   (South Korea)

^b Asan Institute for Life Sciences   (South Korea)

Author keywords

Follicular neoplasm; Medullary carcinoma; Papillary carcinoma; Promyelocytic leukaemia protein (PML); Thyroid

Indexed keywords

ANTIGEN; ONCOPROTEIN;

ANTIGEN RETRIEVAL; ARTICLE; CONTROLLED STUDY; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; IMMUNOPRECIPITATION; MICROSCOPY; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; PROMYELOCYTIC LEUKEMIA; PROTEIN EXPRESSION; THYROID TUMOR;

ADENOCARCINOMA; ADENOMA; CARCINOMA, MEDULLARY; CARCINOMA, PAPILLARY; HUMANS; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; NEOPLASM PROTEINS; NUCLEAR PROTEINS; THYROID GLAND; THYROID NEOPLASMS; TRANSCRIPTION FACTORS; TUMOR SUPPRESSOR PROTEINS;

EID: 0033772747     PISSN: 03090167     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2559.2000.01004.x     Document Type: Article

References (19)

1. Structure and function in the nucleus
2. The PML nuclear compartment and cancer
3. The PML growth-uppressor has an altered expression in human oncogenesis
4. Nuclear domain 10 (ND10) associated proteins are also present in nuclear bodies and redistribute to hundreds of nuclear sites after stress
5. Cystine starvation induces reversible large body formation from nuclear bodies in T24 cells
6. A novel macromolecular structure is a target of the promyelocytic-retinoic acid receptor oncoprotein
7. Retinoic acid regulates aberrant nuclear localization of PML-RAR in acute promyelocytic leukemia cells
8. PML nuclear bodies are general targets for inflammation and cell proliferation
9. Heterogeneous nuclear expression of the promyelocytic leukemia (PML) protein in normal and neoplastic human tissues
10. Altered expression of the growth and transformation suppressor PML gene in human hepatocellular carcinomas and in hepatitis tissues
11. A novel nuclear substructure ND10: Distribution in normal and neoplastic human tissues
12. 1991 Cancer incidence in Seoul, Korea: Results of the Implementation Study of the Seoul Cancer Registry
13. The PML and PML/RAR domains: From autoimmunity to molecular oncology and from retinoic acid to arsenic
14. Altered retinoic acid receptors
15. Telomerase-negative immortalized human cells contain a novel type of promyelocytic leukemia (PML) body
16. PML is expressed in chronic graft-versus-host disease lesions
17. Molecular defects in thyroid carcinomas: Role of the RET oncogene in thyroid neoplastic transformation
18. The RET proto-oncogene in medullary and papillary thyroid carcinoma: Molecular features, pathophysiology and clinical implications
19. Detection of a novel type of RET rearrangement (PTC5) in thyroid carcinomas after Chernobyl and analysis of the involved RET-fused gene RFGS